Urologic Oncology: Seminars and Original Investigations

Overview of contents
pp. 85-86(2)
Author: Prout G.R.

The use of molecular diagnostics in bladder cancer
pp. 87-92(6)
Authors: Han M.; Schoenberg M.P.

Chemotherapy for prostate cancer
pp. 93-96(4)
Authors: Wang J.; Waxman J.

The pattern of serum markers in patients with androgen-independent adenocarcinoma of the prostate
pp. 97-103(7)
Authors: Kim J.; Palmer J.L.; Finn L.; Hodges S.; Bowes V.; Deftos L.; Murphy G.; Logothetis C.

Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate
pp. 104-107(4)
Authors: Bernstein M.R.; Cangiano T.; D'Amico A.; Chittams J.; Hardy C.; Whittington R.D.; Tomaszewski J.E.; Schnall M.D.; Wein A.J.; Malkowicz S.B.

Carcinoid tumor of the kidney - The use of somatostatin receptor scintigraphy in diagnosis and management
pp. 108-111(4)
Authors: McCaffrey J.A.; Reuter V.; Herr H.W.; Macapinlac H.A.; Russo P.; Motzer R.J.

The role of external beam irradiation in patients undergoing prostate brachytherapy
pp. 112-117(6)
Authors: Potters L.; Cha C.; Ashley R.; Freeman K.; Waldbaum R.; Wang X.-H.; Leibel S.

Expression of the multidrug resistance gene in human prostate cancer
pp. 118-121(4)
Authors: Bhangal G.; Halford S.; Wang J.; Roylance R.; Shah R.; Waxman J.